-
No.1 Scheffler fires sizzling 61 to seize PGA St. Jude lead
-
Arteta tells Arsenal fans not to fret over his future
-
Venezuela frees more political prisoners amid post-Maduro talks
-
Mexico's Indigenous chief justice hits back at discrimination
-
Werro upstages Hodgkinson to win thrilling Euro 800m gold
-
Werro wins 800m race for the ages, Warholm and Tamberi hit four
-
Werro upstages Hodgkinson to win Euro 800m gold
-
Jimenez rescues dramatic Wolves draw in Championship opener
-
Hurricane poised to hit Hawaii as El Nino stirs Pacific
-
Taliban govt to mark five years ruling Afghanistan
-
Ex-Cambridge professor at centre of plagiarism scandal found dead
-
Stocks slip in cautious trading after weak US retail sales data
-
Wildfire threatens Canada wine region
-
Gramercy Networks Announces New Global Ultra-Low Latency Financial Network Connecting Major Trading Hubs
-
'Normal guy' turned killer over US insurance industry grievances
-
NFL bans Falcons defender Pearce eight games for domestic violence
-
Norway's hurdles king Warholm wins fourth European title
-
US says 19 million recalled eggs pose deadly risk
-
Liverpool deal with Bezos consortium raises stakes in US battle for Premier League power
-
Former Cincinnati contenders suffer contrasting first-round fates
-
Colombia hopes for miracles as search for quake victims goes on
-
Argentina's Romero confirms Tottenham exit as Atletico move looms
-
Popovici, Quadarella mine more gold at Europeans as Marchand flexes in butterfly
-
Homeless, jobless: Colombia quake survivors 'left with nothing'
-
'I shot Mr Thompson': Stunning confession in US health exec's slaying
-
Cubans find rest on rooftops as blackouts drive them from home
-
San Francisco to host 2028 MLB All-Star Game
-
World champ McIntosh crashes out of Pan Pacs 400m free
-
Trump dismisses concerns over conditions on US aircraft carrier
-
T'Wolves set Garnett celebration for Celtics clash
-
Zambia resumes vote count after pause over violence
-
Popovici nails freestyle double with third men's European 200m gold
-
Wind spurs forest fire in western Germany, with scores evacuated
-
Premier League club Liverpool sell minority stake to Jeff Bezos consortium
-
Pakistan captain Babar in injury scare ahead of England opener
-
Italian police recover stolen Renoir, Cezanne and Matisse works
-
Mangione admits shooting health care CEO
-
Stocks slip in cautious trading, oil turns higher
-
UN warns sanctions chill is stopping Cuba aid
-
Colombia quake survivor faces life without triplet sisters
-
Alleged US healthcare CEO killer says will plead guilty to stalking
-
Bones of medieval kings saved from Spanish wildfire
-
France's Macron in hot water over jet ski picture
-
US retail sales weakest in over a year, consumer sentiment plunges
-
Nursing federation demands proper pay, protection on Ebola front line
-
In wildfire town, PM says UK must 'face up to climate change'
-
France upholds assisted dying law, strikes down social media ban for children
-
In town hit by wildfire, PM says UK must 'face up to climate change'
-
Body found after wildfire hits Croatian coastal town
-
UK parliament probe into Farage resumes after polls win
Brazil's banana spider aids erectile dysfunction treatment
Three decades ago, Brazilian researchers began studying a curious side effect from banana spider bites: the toxin left victims with priapism, a painful and persistent erection.
The scientists were inspired to develop a synthetic molecule using some properties of the spider's poison to create a gel to treat erectile dysfunction, which is now undergoing promising clinical trials.
Covered in thick brown hair, and with a maximum size of up to 15 centimeters (six inches), the arachnid is one of the most poisonous in the world.
It is found in several South American countries, and was nicknamed for its common presence in banana plantations, but it is also called the "wandering spider" or "armed spider."
In the southeastern Brazilian state of Minas Gerais, it is found in rural areas as well as urban centers.
At the Ezequiel Dias Foundation (FUNED), a medical research center in the state's capital Belo Horizonte, a biologist delicately grabs one of the spiders with a pair of tweezers and stimulates its fangs to get a few drops of venom.
FUNED then sends the venom to the Federal University of Minas Gerais (UFMG) which has been researching which component could be replicated to treat erectile dysfunction, which affects tens of millions of men around the world.
"The venom is only used to learn the properties of the molecule" which causes the priapism in bite victims, said Maria Elena de Lima, a UFMG researcher.
Brazilian biotech company Biozeus has bought the patent for the molecule.
The company wants to sell it in an ointment, which would be rubbed on the penis when required, resulting in an erection in a few minutes, said de Lima.
The molecule triggers the release of nitric oxide, which is essential for an erection as it increases blood circulation and allows blood vessels to widen.
De Lima said the research could be especially useful in the fight against cancer, as men suffering prostate cancer often refuse a procedure to remove the prostate because it can damage nerves and lead to erectile dysfunction.
After the first phase of clinical trials was approved by Brazil's Anvisa regulatory agency, the medication has now moved into the second of three phases prior to being approved for sale.
De Lima said the discovery of a potential erectile dysfunction treatment was a message "not to destroy animals, even poisonous ones, because there is a real library of molecules that are still unknown."
Z.Ramadan--SF-PST